India’s young sensation, Prithvi Shaw is banned till 15 November following a doping violation. A BCCI release revealed that Shaw had “inadvertently ingested a prohibited substance, which can be commonly found in cough syrups” during the Syed Mushtaq Ali tournament earlier this year.
His urine sample was tested and found to contain Terbutaline. “Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances,” the BCCI release revealed.
Shaw was charged under the BCCI Anti-doping Rules on July 16 and his ban backdated to eight months. Shaw admitted to the mistake but asserted that it was just a mistake. The BCCI were comvinced that there was no intention of enhancing his performances with the drug and that Shaw had taken an over the counter medicine without thinking following cough and cold symptoms.
“Because Mr. Shaw promptly admitted his ADRV upon being confronted with it by the BCCI, there is discretion under BCCI ADR Article 10.10.2 to back-date the start of the period of Ineligibility to the date of sample collection (22nd February 2019). However, the BCCI ADR Article 10.10.2 also requires Mr. Shaw to actually serve one half of the period of ineligibility. Therefore, further to BCCI ADR Article 10.10.2, the eight-month period of Ineligibility will be deemed to have started to run on 16th March 2019, so that it will end at midnight on 15th November 2019,” the BCCI statement said.
He cannot appear till November 15 now and is ruled out of the home series against Bangladesh and South Africa. He had made a memorable debut in Test cricket against West Indies but returned from Australia following an injury. He is yet to return to the Indian side following that and the latest ban will see him miss further action.
— Prithvi Shaw (@PrithviShaw) July 30, 2019
Vidarbha’s Akshay Dullarwar and Rajasthan’s Divya Gajraj were also suspended for doping violations. Shaw later put up a social media post clarifying that it was an honest mistake on his part.